Back to School: How biopharma can reboot drug development. Access exclusive analysis here

ISV-120 DuraSite eyedrop formulation of batimastat: Began Phase II trial in 40 patients who have had surgery to remove a primary pterygium, to compare efficacy

InSite Vision Inc. (INSV), Alameda, Calif.
Product: ISV-120

Read the full 87 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE